X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (207) 207
index medicus (177) 177
cardiac & cardiovascular systems (174) 174
male (153) 153
female (146) 146
middle aged (134) 134
aged (122) 122
treatment outcome (100) 100
percutaneous coronary intervention (91) 91
clopidogrel (82) 82
ticlopidine - analogs & derivatives (63) 63
cardiovascular (62) 62
abridged index medicus (55) 55
stents (53) 53
risk factors (52) 52
thrombosis (49) 49
aspirin (46) 46
heart attacks (46) 46
time factors (46) 46
care and treatment (45) 45
platelet aggregation inhibitors - therapeutic use (45) 45
peripheral vascular disease (43) 43
platelet aggregation inhibitors - administration & dosage (43) 43
follow-up studies (41) 41
adult (40) 40
mortality (40) 40
hematology (39) 39
myocardial infarction (36) 36
cardiac patients (35) 35
cardiology (35) 35
acute coronary syndromes (34) 34
prospective studies (33) 33
drug therapy, combination (30) 30
angioplasty (29) 29
antiplatelet therapy (29) 29
cardiology and cardiovascular medicine (29) 29
myocardial infarction - therapy (29) 29
platelet reactivity (29) 29
ticlopidine - administration & dosage (29) 29
coronary vessels (28) 28
drug therapy (28) 28
transluminal angioplasty (28) 28
aged, 80 and over (27) 27
bleeding (27) 27
therapy (27) 27
angioplasty, balloon, coronary (26) 26
electrocardiography (26) 26
medical and health sciences (26) 26
medicin och hälsovetenskap (26) 26
myocardial-infarction (26) 26
hemorrhage - chemically induced (25) 25
internal medicine (25) 25
stent thrombosis (25) 25
ticlopidine - therapeutic use (25) 25
cardiovascular disease (24) 24
drug-eluting stents (24) 24
platelet function tests (24) 24
risk (24) 24
acute myocardial-infarction (23) 23
anticoagulants (23) 23
intervention (23) 23
percutaneous coronary intervention - adverse effects (23) 23
stroke (23) 23
clinical medicine (22) 22
implantation (22) 22
metaanalysis (22) 22
reperfusion (22) 22
retrospective studies (22) 22
stent (22) 22
coronary artery disease (21) 21
heart attack (21) 21
klinisk medicin (21) 21
patients (21) 21
prasugrel (21) 21
predictive value of tests (21) 21
studies (21) 21
atrial fibrillation (20) 20
dual antiplatelet therapy (20) 20
percutaneous coronary intervention - methods (20) 20
platelet aggregation inhibitors - adverse effects (20) 20
coronary angiography (19) 19
double-blind method (19) 19
outcomes (19) 19
prognosis (19) 19
risk assessment (19) 19
task-force (19) 19
aspirin - administration & dosage (18) 18
blood platelets (18) 18
coronary heart disease (18) 18
myocardial infarction - drug therapy (18) 18
patient outcomes (18) 18
platelet aggregation - drug effects (18) 18
ticagrelor (18) 18
anticoagulants - therapeutic use (17) 17
blood platelets - drug effects (17) 17
cardiac and cardiovascular systems (17) 17
clinical trials (17) 17
coronary thrombosis - etiology (17) 17
dose-response relationship, drug (17) 17
guidelines (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heart, ISSN 1355-6037, 02/2011, Volume 97, Issue 3, p. 263
Journal Article
Nature Reviews Cardiology, ISSN 1759-5002, 06/2017, Volume 14, Issue 6, pp. 321 - 322
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Blood Coagulation & Fibrinolysis, ISSN 0957-5235, 09/2019, Volume 30, Issue 6, pp. 263 - 269
High on-treatment platelet reactivity (HPR) on P2Y12-inhibitors in patients treated with dual antiplatelet therapy is strongly associated with adverse... 
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 06/2016, Volume 69, Issue 6, p. 608
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2017, Volume 70, Issue 4, pp. 481 - 488
Twenty years after the introduction of alcohol septal ablation (ASA) for the treatment of obstructive hypertrophic cardiomyopathy, the arrhythmogenicity of the... 
septal reduction therapy | patient selection | sudden cardiac death | treatment outcome | heart team
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 11, pp. 999 - 1010
Journal Article